Skip to main content
. 2011 Feb 22;17(5-6):353–362. doi: 10.2119/molmed.2011.00020

Figure 3.

Figure 3

Pharmacokinetics of ITF2357 in healthy male subjects during seven daily doses. (A) Mean (± SD) plasma concentrations of ITF2357 after the first single oral dose are shown. (B) Mean (± SD) plasma ITF2357 on day 7 after seven daily doses. n = 8 in each group.